Low-dose vemurafenib induces complete remission in a case of hairy-cell leukemia with a V600E mutation

• Frederic Peyrade,
• Daniel Re,
• Clemence Ginet,
• Lauris Gastaud,
• Maryline Allegra,
• Robert Ballotti,
• Antoine Thyss,
• Thorsten Zenz,
• Patrick Auberger,
• Guillaume Robert

Affiliations

Frederic Peyrade

Department of Medical Oncology, Centre Antoine Lacassagne, Nice, France

Daniel Re

Department of Medical Oncology, Centre Antoine Lacassagne, Nice, France

Clemence Ginet

INSERM U1065, TEAM1 and TEAM2, Nice, France

Lauris Gastaud

Department of Medical Oncology, Centre Antoine Lacassagne, Nice, France

Maryline Allegra

INSERM U1065, TEAM1 and TEAM2, Nice, France

Robert Ballotti

INSERM U1065, TEAM1 and TEAM2, Nice, France

Antoine Thyss

Department of Medical Oncology, Centre Antoine Lacassagne, Nice, France

Thorsten Zenz

University Hospital Heidelberg, Heidelberg, Germany

Patrick Auberger

INSERM U1065, TEAM1 and TEAM2, Nice, France

Guillaume Robert

INSERM U1065, TEAM1 and TEAM2, Nice, France